Advertisement
Screener

FITLIFE BRANDS, INC. (FTLF) Stock Issued During Period, Value, Stock Options Exercised

FITLIFE BRANDS, INC. Stock Issued During Period, Value, Stock Options Exercised

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $44.00K.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $638.00K.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $682.00K, a 3911.76% increase from fiscal 2024.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $17.00K, a 183.33% increase from fiscal 2023.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $6.00K, a 79.31% decline from fiscal 2022.
  • FITLIFE BRANDS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $29.00K, a 46.30% decline from fiscal 2021.
Period endStock Issued During Period, Value, Stock Options Exercised 3 monthStock Issued During Period, Value, Stock Options Exercised 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$682.00K
10-K · filed 2026-03-31
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
2025-06-30$44.00K
10-Q · filed 2026-08-13
2025-03-31$638.00K
10-Q · filed 2026-05-14
2024-12-31$17.00K
10-K · filed 2026-03-31
2023-12-31$6.00K
10-K · filed 2025-03-27
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$29.00K
10-K · filed 2024-03-29
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$29.00K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$29.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$20.00K
10-Q · filed 2023-05-15
$74.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
$54.00K
10-K · filed 2023-03-24
2021-09-30$0.00
10-Q · filed 2021-11-12
2021-06-30$54.00K
10-Q · filed 2022-10-14
2020-12-31$0.00
derived: 10-K/A 12 month − 10-K/A 9 month · filed 2022-10-13
$71.00K
10-K/A · filed 2022-10-13
2020-09-30$0.00
10-Q · filed 2021-11-12
2020-06-30$0.00
derived: 10-K/A 6 month − 10-K/A 3 month · filed 2022-10-13
2020-03-31$71.00K
10-K/A · filed 2022-10-13
2019-03-31$0.00
10-K/A · filed 2022-10-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87